Matthew S. Rizzo is a Managing Director focused on healthcare royalty and structured finance investments. Previously, Mr. Rizzo was at Ikaria Holdings as a Senior Director in business development for pharmaceutical licensing and acquisitions. Prior to Ikaria, Mr. Rizzo was a Vice President at Fortress Investment Group, focused on healthcare investments in the Drawbridge Special Opportunities Funds. Prior to Fortress, he was at GlaxoSmithKline where he worked in business and commercial analysis. Mr. Rizzo received his M.B.A. from Duke University and his B.S. from the State University of New York at Buffalo.

Back to Top

Matthew L. Wotiz is a Principal focused on healthcare royalty and structured finance investments. Prior to joining OrbiMed, Mr. Wotiz worked at Paul Capital Healthcare, where he was focused on sourcing and executing royalty and structured finance investments. Prior to Paul Capital Healthcare, he held various roles in the corporate development group at Lundbeck, focused on international business development projects. Mr. Wotiz received his M.S. in Biotechnology from the J.L. Kellogg Center for Biotech at Northwestern University and his B.S. from Washington and Lee University.

Back to Top

J. Christopher LiPuma is an Associate focused on healthcare royalty and structured finance investments. Prior to joining OrbiMed, he was an analyst at Cowen Healthcare Royalty Partners. Prior to Cowen, Mr. LiPuma was an analyst in the investment banking groups at Leerink Swann and Bear Stearns. Mr. LiPuma holds a B.A. from Hamilton College.

Back to Top